William E. Heydorn

1.7k total citations
47 papers, 948 citations indexed

About

William E. Heydorn is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Spectroscopy. According to data from OpenAlex, William E. Heydorn has authored 47 papers receiving a total of 948 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 13 papers in Cellular and Molecular Neuroscience and 12 papers in Spectroscopy. Recurrent topics in William E. Heydorn's work include Advanced Proteomics Techniques and Applications (11 papers), Neuroscience and Neuropharmacology Research (9 papers) and Mass Spectrometry Techniques and Applications (6 papers). William E. Heydorn is often cited by papers focused on Advanced Proteomics Techniques and Applications (11 papers), Neuroscience and Neuropharmacology Research (9 papers) and Mass Spectrometry Techniques and Applications (6 papers). William E. Heydorn collaborates with scholars based in United States, Czechia and Canada. William E. Heydorn's co-authors include G. Joseph Creed, Marcelo M. Gutierrez, Adelaide S. Robb, Karen Dineen Wagner, Robert L. Findling, David M. Jacobowitz, Alan Frazer, D.M. Jacobowitz, David J. Brunswick and Paul J. Marangos and has published in prestigious journals such as Proceedings of the National Academy of Sciences, American Journal of Psychiatry and Neurology.

In The Last Decade

William E. Heydorn

46 papers receiving 904 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
William E. Heydorn United States	19	287	253	180	176	129	47	948
F.S. Messiha United States	17	229 0.8×	168 0.7×	120 0.7×	262 1.5×	114 0.9×	114	997
Javaid I. Javaid United States	17	195 0.7×	256 1.0×	85 0.5×	245 1.4×	100 0.8×	34	727
Earl Usdin United States	17	468 1.6×	262 1.0×	119 0.7×	511 2.9×	214 1.7×	43	1.5k
Saburo Takahashi Japan	15	103 0.4×	150 0.6×	109 0.6×	196 1.1×	58 0.4×	43	773
Aron D. Mosnaim United States	20	351 1.2×	294 1.2×	139 0.8×	378 2.1×	202 1.6×	85	1.3k
Odile Spreux‐Varoquaux France	25	492 1.7×	274 1.1×	183 1.0×	408 2.3×	292 2.3×	55	2.0k
Károly Tihanyi Hungary	19	436 1.5×	325 1.3×	52 0.3×	409 2.3×	159 1.2×	51	1.4k
Robert O. Friedel United States	21	402 1.4×	446 1.8×	239 1.3×	343 1.9×	241 1.9×	69	1.4k
Mauno M. Airaksinen Finland	18	303 1.1×	98 0.4×	82 0.5×	336 1.9×	128 1.0×	43	951
William E. Seifert United States	15	454 1.6×	85 0.3×	247 1.4×	209 1.2×	59 0.5×	37	1.2k

Countries citing papers authored by William E. Heydorn

Since Specialization

Citations

This map shows the geographic impact of William E. Heydorn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William E. Heydorn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William E. Heydorn more than expected).

Fields of papers citing papers by William E. Heydorn

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William E. Heydorn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William E. Heydorn. The network helps show where William E. Heydorn may publish in the future.

Co-authorship network of co-authors of William E. Heydorn

This figure shows the co-authorship network connecting the top 25 collaborators of William E. Heydorn. A scholar is included among the top collaborators of William E. Heydorn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William E. Heydorn. William E. Heydorn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Narayanan, Mahesh, et al.. (2023). A Review of the Therapeutic Targeting of SCN9A and Nav1.7 for Pain Relief in Current Human Clinical Trials. Journal of Pain Research. Volume 16. 1487–1498. 18 indexed citations

Powell, David R., Christopher M. DaCosta, Melinda Smith, et al.. (2014). Effect of LX4211 on Glucose Homeostasis and Body Composition in Preclinical Models. Journal of Pharmacology and Experimental Therapeutics. 350(2). 232–242. 44 indexed citations

Wagner, Karen Dineen, et al.. (2004). A Randomized, Placebo-Controlled Trial of Citalopram for the Treatment of Major Depression in Children and Adolescents. American Journal of Psychiatry. 161(6). 1079–1083. 224 indexed citations

Rush, A. John, Anjana Bose, & William E. Heydorn. (2002). Naturalistic study of the early psychiatric use of citalopram in the United States. Depression and Anxiety. 16(3). 121–127. 6 indexed citations

Heydorn, William E.. (2000). Zaleplon - a review of a novel sedative hypnotic used in the treatment of insomnia. Expert Opinion on Investigational Drugs. 9(4). 841–858. 18 indexed citations

Heydorn, William E.. (1999). Paroxetine: a review of its pharmacology, pharmacokinetics and utility in the treatment of a variety of psychiatric disorders. Expert Opinion on Investigational Drugs. 8(4). 417–441. 22 indexed citations

Heydorn, William E.. (1997). Donepezil (E2020): a new acetylcholinesterase inhibitor. Review of its pharmacology, pharmacokinetics, and utility in the treatment of Alzheimer’s disease. Expert Opinion on Investigational Drugs. 6(10). 1527–1535. 28 indexed citations

Heydorn, William E.. (1997). The 98th Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics. Expert Opinion on Investigational Drugs. 6(4). 453–457. 5 indexed citations

Peyster, R G, N. M. Sussman, Beverly L. Hershey, et al.. (1995). Use of Ex Vivo Magnetic Resonance Imaging to Detect Onset of Vigabatrin‐Induced Intramyelinic Edema in Canine Brain. Epilepsia. 36(1). 93–100. 41 indexed citations

10.

Heydorn, William E.. (1995). Monthly Update Central & Peripheral Nervous Systems: Nefazodone - a summary of the available data on a new antidepressant agent. Expert Opinion on Investigational Drugs. 4(2). 131–137. 1 indexed citations

11.

Heydorn, William E.. (1995). Section Review Central & Peripheral Nervous Systems: Mirtazapine - a novel antidepressant compound currently undergoing clinical evaluation. Expert Opinion on Investigational Drugs. 4(10). 945–954. 2 indexed citations

12.

Heydorn, William E.. (1994). Meeting Highlights: Focus on new advancements in the areas of headache management, substance abuse and Alzheimer's disease: general regulatory issues: in vitro pharmacokinetics and toxicology. Expert Opinion on Investigational Drugs. 3(6). 647–651. 2 indexed citations

13.

Sussman, Neil M. & William E. Heydorn. (1994). New and investigational antiepilepsy drugs. Expert Opinion on Investigational Drugs. 3(4). 355–368. 7 indexed citations

14.

Olsen, Kathie L., William E. Heydorn, Jorge F. Rodriguez‐Sierra, & David M. Jacobowitz. (1989). Quantification of Proteins in Discrete Brain Regions of Androgen-Insensitive Testicular Feminized <i>Tfm</i> Mice. Neuroendocrinology. 50(4). 392–399. 4 indexed citations

15.

Rodriguez‐Sierra, Jorge F., William E. Heydorn, G. Joseph Creed, & David M. Jacobowitz. (1987). Incorporation of Amino Acids into Proteins of the Hypothalamus of Prepuberal Female Rats after Estradiol Treatment. Neuroendocrinology. 45(6). 459–464. 6 indexed citations

16.

Heydorn, William E., G. Joseph Creed, Cyrus R. Creveling, & D.M. Jacobowitz. (1986). Studies on catechol-O-methyltransferase in rat brain using two-dimensional gel electrophoresis. Neurochemistry International. 8(4). 581–586. 7 indexed citations

17.

Heydorn, William E., et al.. (1985). Proteins Regulated by Gonadal Steroids in the Medial Preoptic and Ventromedial Hypothalamic Nuclei of Male and Female Rats. Neuroendocrinology. 41(3). 237–245. 29 indexed citations

18.

Heydorn, William E., G. Joseph Creed, & D.M. Jacobowitz. (1984). Effect of desmethylimipramine and reserpine on the concentration of specific proteins in the parietal cortex and the hippocampus of rats as analyzed by two-dimensional gel electrophoresis.. Journal of Pharmacology and Experimental Therapeutics. 229(2). 622–628. 25 indexed citations

19.

Gold, Mark, et al.. (1983). Sex Differences in Specific Proteins in the Preoptic Medial Nucleus of the Rat Hypothalamus. Neuroendocrinology. 37(6). 470–472. 8 indexed citations

20.

Heydorn, William E., David J. Brunswick, & Alan Frazer. (1982). Effect of treatment of rats with antidepressants on melatonin concentrations in the pineal gland and serum.. Journal of Pharmacology and Experimental Therapeutics. 222(3). 534–543. 59 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact